Fear of increasing blood clotting, now in Germany for people under 60 years of age, stop the Coronavirus Vaccine of AstraZeneca.
The decision of suspending the routine use of the AstraZeneca vaccine for people under age 60 has been taken recently after reports of abnormal blood clot formation in people taking the vaccine. Health officials in Berlin Germany announced on Tuesday that the use of the AstraZeneca CoronaVirus vaccine was once again being suspended for people under 60 years of age. The decision comes after reports of recent blood clotting among people taking the vaccine came to light. Officials in Berlin, Munich and the eastern province of Brandenburg pronounced to temporarily stop the vaccination.
Regarding this matter, representatives of 16 states of Germany will meet on Tuesday. The country's medical regulator said that as of March 29, a total of 31 reports of blood clotting in people getting the AstraZeneca vaccine were received. Among them, Nine have died and in most cases were aged between 20 and 63 years.
Chancellor Angela Merkel and Health Minister Jens Spahn are scheduled to hold a press conference late Tuesday night on the conclusion of their meeting with the states. Earlier, on Monday, Canada stopped the introduction of the Covid-19 vaccine developed by Oxford AstraZeneca to people under 55 years of age. The government took this conclusion in view of the possibility of a vaccine related to the rare occurrence of blood clots in this age group.
The Brief. Sign up to receive the top stories you need to know right now.